Biological Behavior of Mucoepidermoid Carcinoma of the Esophagus

Journal of Nippon Medical School

Volumn 70, Issue 5, 2003, Pages 401-407

  Hagiwara, Nobutoshi ^a   Tajiri, Takashi ^a   Miyashita, Masao ^a   Sasajima, Koji ^a   Makino, Hiroshi ^a   Matsutani, Takeshi ^a   Tsuchiya, Yoshikazu ^a   Takubo, Kaiyo ^b   Yamashita, Kiyohiko ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Graduate School of Medicine ^*

Author keywords

Esophagus; Immunohistochemistry; Mucoepidermoid carcinoma; P53; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYCLINE; PROTEIN P53;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, MUCOEPIDERMOID; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 0242558031     PISSN: 13454676     EISSN: None     Source Type: Journal    
DOI: 10.1272/jnms.70.401     Document Type: Article

References (26)

1. Suzuki H, Nagayo T: Primary tumors of the esophagus other than squamous cell carcinoma: histologic classification and statistics in the surgical and autopsied materials in Japan. Int Adv Surg Oncol 1980; 3: 73-109.
2. Lieberman MD, Franceschi D, Marsan B, Burt M: Esophageal carcinoma; The unusual variants. J Thorac Cardiovasc Surg 1994; 108: 1138-1146.
3. Osamura RY, Sato S, Miwa T: Mucoepidermoid carcinoma of the esophagus: report of an unoperated autopsy case and review of the literature. Am J Gastroenterol 1978; 69: 467-470.
4. Takubo K, Takai A, Yamashita K, Onda M: Carcinoma with signet ring cells of the esophagus. Acta Pathol Jpn 1987; 37: 989-995.
5. Ozawa S, Ando N, Shinozawa Y, et al: Two cases of resected esophageal mucoepidermoid carcinoma. Jpn J Surg 1989; 19: 86-89.
6. Sasajima K, Watanabe M, Takubo K, et al: Mucoepidermoid carcinoma of the esophagus: report of two cases and review of literature. Endoscopy 1990; 22: 140-143.
7. Kinugasa S, Tachibana M, Hishikawa Y, et al: Prognostic significance of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the esophagus. Jpn J Clin Oncol 1996; 26: 405-410.
8. Lam KY, Law SY, So MK, et al: Prognositic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma. Cancer 1996: 77: 7-13.
9. Edwards JM, Hillier VF, Lawson RA, et al: Squamous cell carcinoma of the oesophagus: histological criteria and their prognostic significance. Br J Cancer 1989; 59: 429-433.
10. Morisaki Y, Shima S, Yoshizumi Y, et al: PCNA immunostaining combined with AgNOR staining in esophageal squamous cell carcinoma to identify patients with a poor prognosis. Surg Today 1995; 25: 389-395.
11. nd Ed, Berlin, Springer Verlag 1990; 13.
12. Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 1993; 329: 1318-1327.
13. Shimaya K, Shiozaki H, Inoue M, et al: Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows Arch A Pathol Anat Histopathol 1993; 422: 271-276.
14. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
15. rd Ed, Fasc 17, Washington DC, Armed Forces Institute of Pathology 1996: 155-175.
16. Sekiguchi H, Akiyama S, Fujiwara M, et al: Phase II trial of 5-fluorouracil and low-dose cisplatin in patients with squamous cell carcinoma of the esophagus. Surg Today 1999; 29: 97-101.
17. Vogel SB, Mendenhall WM, Sombeck MD, et al: Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 1995; 221: 693-695.
18. Chanvitan A, Nekarda H, Casson AG: Prognositic value of DNA index, S-phase fraction and p53 protein accumulation after surgical resection of esophageal squamous-cell carcionoma in Thailand. Int J Cancer 1995; 63: 381-386.
19. Sgambato A, Han EK, Zhang YJ, et al: Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis 1995; 16: 2193-2198.
20. Nakano H, Nakatame K, Nakayoshi A, Kumada K: The evaluation of cellular proliferating activity in gastric carcinoma with the proliferating cell nuclear antigen (PCNA) expressive rate: its fundamental examination of the immunohistochemical procedures and its clinical applications. J Jpn Surg Soc 1993; 94: 580-592.
21. Kevin H, David G, Iona MR, et al: Expression of epidermal growth factor receptor and proliferating cell nuclear anigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 1994; 74: 1693-1698.
22. Desai GR, Myerson RJ, Higashikubo R, et al: Carcinoma of the rectum. Possible cellular predictors of metastatic potential and response to radiation therapy. Dis Colon Rectum 1996; 39: 1090-1096.
23. Hostetter RB, Campbell DE, Chi KF, et al: Carcinoembryonic antigen enhances metastatic potential of human colorectal carcinoma. Arch Surg 1990; 125: 300-304.
24. Clark GW, Ireland AP, Hagen JA, et al: Carcinoembryonic antigen measurements in the management of esophageal cancer: an indicator of subclinical recurrence. Am J Surg 1995; 170: 597-600.
25. Majuri ML, Hakkarainen M, Paavonen T, Renkonen R: Carcinoembryonic antigen is expressed on endothelial cells. A putative mediator of tumor cell extravasation and metastasis. APMIS 1994; 102: 432-438.
26. Sanders DS, Wilson CA, Bryant FJ, et al: Classification and localisation of carcinoembryonic antigen (CEA) related antigen expression in normal oesophageal squamous mucosa and squamous carcinoma. Gut 1994; 35: 1022-1025.